ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

BLUE Company Profile and Key Details

NASDAQ : BLUE

bluebird bio, Inc.

$4.00

-0.11-2.68%

At Close 4:00 PM

62.53

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

BLUE Stock Price Chart

Stock Price Today

bluebird bio, Inc. (BLUE) stock declined over -2.68%, trading at $4.00 on NASDAQ, down from the previous close of $4.11. The stock opened at $4.06, fluctuating between $3.95 and $4.14 in the recent session.

Stock Snapshot

4.11

Prev. Close

4.06

Open

38.96M

Market Cap

9.74M

Number of Shares

3.945

Day Low

4.135

Day High

-0.11

P/E Ratio

98.9%

Free Float in %

-36

EPS (TTM)

2.04

Book Value

-2.63

Cash Flow per Share

132.56K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 07, 2025	4.06	4.14	3.94	4.00	134.08K
Mar 06, 2025	3.90	4.13	3.86	4.11	213.91K
Mar 05, 2025	3.86	4.05	3.82	4.00	306.73K
Mar 04, 2025	3.83	3.96	3.75	3.82	276.83K
Mar 03, 2025	4.02	4.09	3.84	3.88	266.4K
Feb 28, 2025	3.76	4.08	3.72	4.08	272.3K
Feb 27, 2025	3.87	3.97	3.75	3.80	200.24K
Feb 26, 2025	3.93	4.04	3.84	3.86	342K
Feb 25, 2025	3.85	4.13	3.85	4.02	388.78K
Feb 24, 2025	4.00	4.05	3.56	4.05	1.66M
Feb 21, 2025	4.90	5.65	4.00	4.08	5.44M
Feb 20, 2025	7.24	7.25	6.88	7.04	94.4K
Feb 19, 2025	7.01	7.25	6.61	7.25	240.74K
Feb 18, 2025	7.34	7.55	6.95	7.12	149.32K
Feb 14, 2025	7.30	7.54	7.02	7.27	183.83K
Feb 13, 2025	6.44	7.42	6.20	7.25	285.79K
Feb 12, 2025	5.94	6.41	5.90	6.39	109.87K
Feb 11, 2025	6.25	6.29	5.91	6.05	181.41K
Feb 10, 2025	6.31	6.33	6.07	6.29	127.55K
Feb 07, 2025	6.86	6.92	6.10	6.29	313.14K

Contact Details

Cambridge, MA 02142

United States

Website: https://www.bluebirdbio.comContact: 339 499 9300

About Company

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.

Frequently Asked Questions

What is the current bluebird bio, Inc. (BLUE) stock price?

bluebird bio, Inc. (NASDAQ: BLUE) stock price is $4.00 in the last trading session. During the trading session, BLUE stock reached the peak price of $4.14 while $3.95 was the lowest point it dropped to. The percentage change in BLUE stock occurred in the recent session was -2.68% while the dollar amount for the price change in BLUE stock was -$0.11.

BLUE's industry and sector of operation?

The NASDAQ listed BLUE is part of Biotechnology industry that operates in the broader Healthcare sector. bluebird bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BLUE?

Sarah Alspach
Chief Communications Officer
Dr. Liviu Niculescu M.D., Ph.D.
Senior Vice President of Global Medical Affairs
Mr. Richard Colvin M.D., Ph.D.
Chief Medical Officer
Mr. Christopher Krawtschuk CPA
Chief Financial Officer, Principal Accounting Officer & Treasurer
Mr. Thomas J. Klima
Chief Commercial Officer & Chief Operating Officer
Ms. Elizabeth Pingpank
Director of Corporation Communications
Mr. Scott Shoemaker
Senior Vice President of Quality
Ms. Melissa Bonner
Senior Vice President of Research
Jess Rowlands
Head of Corporation Communications
Mr. Christopher Krawtschuk C.P.A.
Chief Financial Officer, Principal Accounting Officer & Treasurer
Ms. Andrea Walton
Chief People Officer
Mr. Andrew Obenshain
Pres, Chief Executive Officer & Director
Mr. Richard A. Colvin M.D., Ph.D.
Chief Medical Officer
Mr. Kasra Kasraian
Senior Vice President of Technical Devel. & Operations
Mr. Joseph D. Vittiglio Esq., J.D.
Chief Bus. & Legal Officer and Corporation Sec.

How BLUE did perform over past 52-week?

BLUE's closing price is 12.36% higher than its 52-week low of $3.56 where as its distance from 52-week high of $33.20 is -87.95%.

How many employees does BLUE have?

Number of BLUE employees currently stands at 282.

Link for BLUE official website?

Official Website of BLUE is: https://www.bluebirdbio.com

How do I contact BLUE?

BLUE could be contacted at phone 339 499 9300 and can also be accessed through its website. BLUE operates from 60 Binney Street, Cambridge, MA 02142, United States.

How many shares of BLUE are traded daily?

BLUE stock volume for the day was 132.56K shares. The average number of BLUE shares traded daily for last 3 months was 408.56K.

What is the market cap of BLUE currently?

The market value of BLUE currently stands at $38.96M with its latest stock price at $4.00 and 9.74M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	282
Beta	0.82
Sales or Revenue	$3.60M
5Y Sales Change%	-0.744%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology